# Volastra Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/volastra-therapeutics

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.volastratx.com
- Total disclosed funding: $104M
- Latest round: Series A (Mar 3, 2023)
- Investors on record: 9

## About

Based in New York, US, and founded in 2019, Volastra Therapeutics, Inc. is a biotechnology company that provides treatment for metastatic cancers. The company was founded by Lewis Cantley, Olivier Elemento, and Samuel Bakhoum, and in March 2023, Volastra Therapeutics, Inc. raised USD 60 million in series A funding co-led by ARCH Venture Partners, Polaris Partners, and Eli Lilly & Company, with participation from Catalio Capital Management, DROIA Ventures, and Vida Ventures. As of 2023, the firm is led by its CEO Charles Hugh-Jones.

Volastra Therapeutics, Inc. develops chromosomal instability (CIN)- targeted novel therapeutics that include KIF18A inhibitor, VLS-1488. 

The company intends to use the March 2023 funding for the clinical development of its KIF18A inhibitor drug portfolio and the advancement of its drug research pipeline for treating chromosomally unstable cancers.

## Funding rounds

- Series A, Mar 3, 2023, $60M — ARCH Venture Partners, Polaris Partners, Meyer Ventures, Eli Lilly & Company, Droia Ventures, Vida Ventures, Cornell University, Catalio Capital Management
- Seed, Apr 6, 2021, $44M — ARCH Venture Partners, Polaris Partners, Droia Ventures, Quark Venture, Vida Ventures, Catalio Capital Management

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Seed, Series A
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Seed, Series A
- Droia Ventures (https://capitalatlas.ai/funds/droia-ventures) — Seed, Series A
- Quark Venture (https://capitalatlas.ai/funds/quark-venture) — Seed
- Vida Ventures (https://capitalatlas.ai/funds/vida-ventures) — Seed, Series A
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Seed, Series A
- Meyer Ventures (https://capitalatlas.ai/funds/meyer-ventures) — Series A
- Eli Lilly & Company — Series A
- Cornell University — Series A